These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 318984

  • 1. Evaluation of two dose levels of loxapine succinate in chronic schizophrenia.
    Clark ML, Paredes A, Costiloe JP, Fulkerson FG, Wood F.
    Dis Nerv Syst; 1977 Jan; 38(1):7-10. PubMed ID: 318984
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of loxapine hydrochloride oral concentrate (loxitane C) in acute schizophrenia.
    Wittkopp TA.
    J Clin Psychiatry; 1978 Feb; 39(2):154-7. PubMed ID: 344304
    [Abstract] [Full Text] [Related]

  • 3. Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
    Schiele BC.
    Dis Nerv Syst; 1975 Jul; 36(7):361-4. PubMed ID: 1097221
    [Abstract] [Full Text] [Related]

  • 4. A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients.
    Moyano CZ.
    Dis Nerv Syst; 1975 Jun; 36(6):301-4. PubMed ID: 238810
    [Abstract] [Full Text] [Related]

  • 5. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
    Paprocki J, Versiani M.
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
    Vianna Filho U, Versiani Caldeira V, Romildo Bueno J.
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
    [No Abstract] [Full Text] [Related]

  • 7. Effects of gradual decrease and discontinuation of neuroleptics on clinical condition and tardive dyskinesia [proceedings].
    Branchey MH, Branehey LB, Richardson MA.
    Psychopharmacol Bull; 1981 Jan; 17(1):118-20. PubMed ID: 7232639
    [No Abstract] [Full Text] [Related]

  • 8. A two year trial of loxapine succinate in chronic psychotic patients.
    Simpson GM, Branchey MH, Lee JH, Varga E.
    Dis Nerv Syst; 1976 May; 37(5):305-7. PubMed ID: 816626
    [Abstract] [Full Text] [Related]

  • 9. Loxapine concentrate in acute schizophrenia.
    O'Connell RA, Jeewa M, Allen K.
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):101-7. PubMed ID: 401704
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB, McClure RF, Helwig H.
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.
    Moore DF.
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):172-80. PubMed ID: 809232
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.